Diffusion-weighted imaging: determination of the best pair of b-values to discriminate breast lesions.

OBJECTIVE In breast diffusion-weighted imaging (DWI), the apparent diffusion coefficient (ADC) is used to discriminate between malignant and benign lesions. As ADC estimates can be affected by the weighting factors, our goal was to determine the optimal pair of b-values for discriminating breast lesions at 3.0 T. METHODS 152 females with 157 lesions (89 malignant and 68 benign) underwent breast MRI, including a DWI sequence sampling six b-values 50, 200, 400, 600, 800 and 1000 s mm(-2). ADC values were computed from different pairs of b-values and compared with ADC obtained by fitting the six b-values using a mono-exponential diffusion model (ADCall). Cut-off ADC values were determined and diagnostic performance evaluated by receiver operating characteristic analysis using Youden statistics. Mean ADCs were determined for normal tissue and lesions. Differences were evaluated by lesion and histological types. RESULTS Considering the cut-off values 1.46 and 1.49 × 10(3)mm(2) s(-1), the pairs 50, 1000 and 200, 800 s mm(-2) showed the highest accuracy, 77.5% and 75.4% with areas under the curve 84.4% and 84.2%, respectively. The best pair for ADC quantification was 50, 1000 s mm(-2) with 38/49 true-negative and 69/89 true-positive cases respectively; mean ADCs were 1.86 ± 0.46, 1.77 ± 0.37 and 1.15 ± 0.46 × 10(-3) mm(2) s(-1) for normal, benign and malignant lesions. There were no significant differences in these ADC values when compared with ADCall (ADC calculated from the full set of b - values) [difference = 0.0075 × 10(-3) mm(2) s(-1); confidence interval 95%: (-0.0036; 0.0186); p = 0.18]. CONCLUSION The diagnostic performance in differentiating malignant and benign lesions was most accurate for the b-value pair 50, 1000 s mm(-2). ADVANCES IN KNOWLEDGE The best b-value pair for lesion discrimination and characterization through ADC quantification was 50, 1000 s mm(-2).

[1]  Savannah C Partridge,et al.  Breast magnetic resonance imaging: diffusion-weighted imaging. , 2013, Magnetic resonance imaging clinics of North America.

[2]  H. Yabuuchi,et al.  Diffusion-weighted imaging (b value = 1500 s/mm2) is useful to decrease false-positive breast cancer cases due to fibrocystic changes , 2013, Breast Cancer.

[3]  T. Coşkun,et al.  Diffusion-weighted MR imaging of the breast: comparison of apparent diffusion coefficient values of normal breast tissue with benign and malignant breast lesions. , 2012, Singapore medical journal.

[4]  K. Arihiro,et al.  Comparisons of multi b‐value DWI signal analysis with pathological specimen of breast cancer , 2012, Magnetic resonance in medicine.

[5]  B. Kiefer,et al.  Combination of chemical suppression techniques for dual suppression of fat and silicone at diffusion-weighted MR imaging in women with breast implants , 2012, European Radiology.

[6]  T. Kwee,et al.  Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review , 2012, Insights into Imaging.

[7]  Celia P. Corona-Villalobos,et al.  Oncologic applications of diffusion‐weighted MRI in the body , 2012, Journal of magnetic resonance imaging : JMRI.

[8]  Tristan Barrett,et al.  Angiogenesis Imaging in Neoplasia , 2011, Journal of clinical imaging science.

[9]  Saadallah Ramadan,et al.  Diffusion-weighted imaging of the breast: principles and clinical applications. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[10]  Wendy B DeMartini,et al.  Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast‐enhanced kinetics , 2011, Magnetic resonance in medicine.

[11]  D. Collins,et al.  Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. , 2011, AJR. American journal of roentgenology.

[12]  Wendy B DeMartini,et al.  Characterization of ductal carcinoma in situ on diffusion weighted breast MRI , 2011, European Radiology.

[13]  Fernanda Philadelpho Arantes Pereira,et al.  Diffusion magnetic resonance imaging of the breast. , 2011, Magnetic resonance imaging clinics of North America.

[14]  Y. Akiyama,et al.  Biexponential Signal Attenuation Analysis of Diffusion-weighted Imaging of Breast. , 2010, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[15]  Peter R Luijten,et al.  Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: The influence of the choice of b‐values , 2010, Journal of magnetic resonance imaging : JMRI.

[16]  M. Oudkerk,et al.  Diffusion‐weighted imaging of normal fibroglandular breast tissue: influence of microperfusion and fat suppression technique on the apparent diffusion coefficient , 2010, NMR in biomedicine.

[17]  Wendy B DeMartini,et al.  Differential diagnosis of mammographically and clinically occult breast lesions on diffusion‐weighted MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[18]  Wendy B DeMartini,et al.  Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. , 2009, AJR. American journal of roentgenology.

[19]  T. Helbich,et al.  Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? , 2009, Radiology.

[20]  Yoshito Tsushima,et al.  Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5‐T , 2009, Journal of magnetic resonance imaging : JMRI.

[21]  S. Sinha,et al.  Recent advances in breast MRI and MRS , 2009, NMR in biomedicine.

[22]  Hiroshi Honda,et al.  Apparent diffusion coefficients of breast tumors: clinical application. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[23]  # The Author(s) 2008 , 2007 .

[24]  Hiromu Nishitani,et al.  Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer , 2008, Radiation Medicine.

[25]  Dow-Mu Koh,et al.  Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[26]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[27]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[28]  Frederik De Keyzer,et al.  Extracranial applications of diffusion-weighted magnetic resonance imaging , 2007, European Radiology.

[29]  S. Rachev,et al.  SIMPLE LINEAR REGRESSION , 2006, Statistical Methods for Biomedical Research.

[30]  Thierry Metens,et al.  Quantitative diffusion imaging in breast cancer: A clinical prospective study , 2006, Journal of magnetic resonance imaging : JMRI.

[31]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Joan Leach,et al.  Expert heads a'rolling Melissa Leach Ian , 2005, The Lancet.

[33]  J. Helpern,et al.  Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[34]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[35]  Massimo Bazzocchi,et al.  Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. , 2004, AJR. American journal of roentgenology.

[36]  Toshibumi Kinoshita,et al.  Hypointensity on diffusion-weighted MRI of the brain related to T2 shortening and susceptibility effects. , 2003, AJR. American journal of roentgenology.

[37]  Naobumi Yashiro,et al.  Diffusion-Weighted Half-Fourier Single-Shot Turbo Spin Echo Imaging in Breast Tumors: Differentiation of Invasive Ductal Carcinoma from Fibroadenoma , 2002, Journal of computer assisted tomography.

[38]  Ning-Yu An,et al.  Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[39]  G C McKinnon,et al.  Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI , 2001, Journal of magnetic resonance imaging : JMRI.

[40]  Terri L. Moore,et al.  Regression Analysis by Example , 2001, Technometrics.

[41]  F. Schmidt,et al.  Magnetic resonance imaging (MRI) of the breast , 1997, Acta Chirurgica Austriaca.

[42]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[43]  Sibel Kul,et al.  Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. , 2011, AJR. American journal of roentgenology.

[44]  R. Birdwell 1H MR Spectroscopy and Diffusion-Weighted Imaging of the Breast: Are They Useful Tools for Characterizing Breast Lesions Before Biopsy? , 2010 .

[45]  Stephan E Maier,et al.  Quantification of water compartmentation in cell suspensions by diffusion-weighted and T(2)-weighted MRI. , 2008, Magnetic resonance imaging.